Shareholders' Equity	12 Months Ended
Mar. 31, 2020
Equity [Abstract]
Shareholders' Equity	NOTE 7 — SHAREHOLDERS’ EQUITY: Common Shares: Authorized common shares total 75,000,000 with a par value $0.01 per share, of which, 21,042,652 were outstanding as of March 31, 2020 and March 31, 2019. Shares held in treasury at March 31, 2020 and March 31, 2019 were 31,923,145. Common Stock Repurchase Program: In December 2016, the Company’s Board of Directors approved a common stock repurchase program under which the Company was authorized to repurchase up to $5 million of its common stock. The Board of Directors subsequently approved an additional $5 million in repurchases and extended the program to December 31, 2018, as of which date the program expired. Under the program, repurchases were funded from available working capital and all repurchased shares are held in the treasury as authorized and issued shares available for general corporate purposes. During the twelve months ended March 31, 2020, the Company repurchased no shares under the program, as the program expired on December 31, 2018. During the twelve months ended March 31, 2019, the Company repurchased 1,756,436 shares for $2,617,858. In aggregate, the Company repurchased 6,087,180 shares for $8,977,096 under the program. Series A Preferred Stock: The Company has issued and outstanding 3,677 shares of Series A Preferred Stock, $.01 par value (“Preferred Stock”), with a face value of $3,677,000, which had no determinable market value as of March 31, 2020. The Preferred Stock is non-voting, has no dividend preferences and has not been convertible since March 31, 2002; however, it retains a liquidation preference.

Shareholders' Equity

12 Months Ended

Mar. 31, 2020

NOTE 7 — SHAREHOLDERS’ EQUITY:

Common Shares:

Authorized common shares total 75,000,000 with a par value $0.01 per share, of which, 21,042,652 were outstanding as of March 31, 2020 and March 31, 2019. Shares held in treasury at March 31, 2020 and March 31, 2019 were 31,923,145.

Common Stock Repurchase Program:

In December 2016, the Company’s Board of Directors approved a common stock repurchase program under which the Company was authorized to repurchase up to $5 million of its common stock. The Board of Directors subsequently approved an additional $5 million in repurchases and extended the program to December 31, 2018, as of which date the program expired. Under the program, repurchases were funded from available working capital and all repurchased shares are held in the treasury as authorized and issued shares available for general corporate purposes.

During the twelve months ended March 31, 2020, the Company repurchased no shares under the program, as the program expired on December 31, 2018. During the twelve months ended March 31, 2019, the Company repurchased 1,756,436 shares for $2,617,858. In aggregate, the Company repurchased 6,087,180 shares for $8,977,096 under the program.

Series A Preferred Stock:

The Company has issued and outstanding 3,677 shares of Series A Preferred Stock, $.01 par value (“Preferred Stock”), with a face value of $3,677,000, which had no determinable market value as of March 31, 2020. The Preferred Stock is non-voting, has no dividend preferences and has not been convertible since March 31, 2002; however, it retains a liquidation preference.